ABMT (Advanced BioMedical Technologies) Change In Receivables: $-0.01 Mil (TTM As of Jul. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced BioMedical Technologies Change In Receivables?

Advanced BioMedical Technologies ABMT Change In Receivables is $-0.01 Mil as of Jul. 2021.

Advanced BioMedical Technologies's change in receivables for the quarter that ended in Jul. 2021 was $0.01 Mil. It means Advanced BioMedical Technologies's Accounts Receivable declined by $0.01 Mil from Apr. 2021 to Jul. 2021 .

Advanced BioMedical Technologies's change in receivables for the fiscal year that ended in Oct. 2020 was $0.02 Mil. It means Advanced BioMedical Technologies's Accounts Receivable declined by $0.02 Mil from Oct. 2019 to Oct. 2020 .

Advanced BioMedical Technologies's Accounts Receivable for the quarter that ended in Jul. 2021 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Advanced BioMedical Technologies's liquidation value for the three months ended in Jul. 2021 was $-8.48 Mil.

Advanced BioMedical Technologies  (OTCPK:ABMT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Advanced BioMedical Technologies's Days Sales Outstanding for the quarter that ended in Jul. 2021 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Advanced BioMedical Technologies's accounts receivable are only considered to be worth 75% of book value:

Advanced BioMedical Technologies's liquidation value for the quarter that ended in Jul. 2021 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.007-8.579+0.75 * 0+0.5 * 0.189
=-8.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Change In Receivables Related Terms

Advanced BioMedical Technologies Change In Receivables Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Change In Receivables Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 -0.02 -0.02 0.02

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.01 -0.03 0.00 0.01

Advanced BioMedical Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jul. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.01 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Change In Receivables of $-0.01 Mil as of Jul. 2021. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Change In Receivables too high?
Advanced BioMedical Technologies' current Change In Receivables is $-0.01 Mil.
How does Advanced BioMedical Technologies' Change In Receivables compare to VYCO and ADMT?
Advanced BioMedical Technologies' Change In Receivables of $-0.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Change In Receivables is $-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Change In Receivables of $-0.01 Mil. The current Change In Receivables is $-0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Change In Receivables is $-0.01 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.